Skip to main content

Table 4 Complications reported for all ELSO registry patients, patients from Children's Healthcare of Atlanta at Egleston alone (CHOA) and ELSO registry patients excluding Children's at Egleston patients (non-CHOA)

From: Experience with use of extracorporeal life support for severe refractory status asthmaticus in children

Organ system dysfunction

All ELSO patients (n = 64)

CHOA alone (n = 13)

ELSO alone (n = 51)

Number of ELSO non-survivors with complication*

CHOA vs. non-CHOA p value

CNS

4 (6%)

2 (14%)

2 (4%)

1

0.153

Cardiovascular

21 (33%)

5 (38%)

16 (31%)

3

0.421

Haemorrhagic

15 (23%)

7 (54%)

8 (16%)

1

0.001**

Mechanical

15 (23%)

4 (31%)

11 (22%)

1

0.276

Pulmonary

9 (14%)

3 (23%)

6 (12%)

2

0.123

Metabolic

20 (31%)

9 (69%)

11 (22%)

1

0.0001**

Renal

12 (18%)

3 (21%)

9 (18%)

2

0.354

Infectious

10 (16%)

7 (54%)

3 (6%)

1

0.0001**

  1. All values expressed in number (percentage). * All patients at Children's at Egleston survived. ** Statistically significant.
  2. CHOA = Children's Healthcare of Atlanta at Egleston; CNS = central nervous system; ELSO = Extracorporeal Life Support Organization.